期刊文献+

HHV-8 K13基因编码蛋白在人血管内皮细胞和前列腺癌细胞系中的表达及其对细胞增殖影响的初探

The eukaryotic expression of HHV-8 K13 and its effect on the proliferation of human endothelial and prostate cancer cells
在线阅读 下载PDF
导出
摘要 目的:研究人类疱疹病毒8型(HHV-8)K13(v-FLIP)基因编码蛋白分别在人血管内皮细胞和前列腺癌细胞中的表达及其对上述两种细胞增殖能力的影响。方法:将PEF-K13-Flag-IRES/Puro重组质粒瞬时转染人血管内皮细胞系EA.HY926细胞和前列腺癌细胞系PC-3细胞,采用Western blot方法检测K13基因编码蛋白表达情况;分别运用流式细胞术和MTT方法检测K13基因编码蛋白对这两种细胞增殖的影响。结果:HHV-8 K13基因编码蛋白能够在人血管内皮细胞和前列腺癌细胞中表达,流式细胞分析和MTT结果显示,HHV-8 K13基因编码蛋白对上述两种细胞的增殖均有明显的抑制作用(P<0.05)。结论:HHV-8 K13基因编码蛋白可以明显抑制人血管内皮细胞和前列腺癌细胞的增殖。 Objective:To investigate the expression protein of HHV-8 K13 in human endothelial and prostate cancer cells respec-tively,and evaluate the effect on the proliferation of the two cell lines.Methods:The recombinant plasmid PEF-K13-Flag-IRES / Puro was transiently trancfected into EA.HY926 cells and PC-3 cells.The expression of K13 protein in both cells was analyzed by Western blot.The function of K13 protein in cell cycle and cell proliferation were measured by flow cytometry and MTT assay,respectively.Results:The specific band of K13 protein was detected at the expected place by Western blot.In addition,the results of the flow cy-tometry and MTT assay showed that the HHV-8 K13 protein could significantly inhibit the proliferation in human endothelial and prostate cancer cells.Conclusion:HHV-8 K13 protein might inhibit the growth of human endothelial and prostate cancer cells.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2011年第1期21-25,共5页 Journal of Nanjing Medical University(Natural Sciences)
基金 中国博士后基金资助(20080441064)
关键词 前列腺癌 人类疱疹病毒8型 K13 PC-3 内皮细胞 prostate cancer HHV-8 K13 PC-3 endothelial cell
  • 相关文献

参考文献2

二级参考文献14

  • 1张思维,陈万青,孔灵芝,李连弟,鲁凤珠,李光琳,孟佳,赵平.中国部分市县1998~2002年恶性肿瘤的发病与死亡[J].中国肿瘤,2006,15(7):430-448. 被引量:171
  • 2李连弟,饶克勤.中国试点市县恶性肿瘤的发病与死亡第1卷(1988-1992).北京:中国医药科技出版社,2002:263-289.
  • 3李连弟,饶克勤.中国试点市县恶性肿瘤的发病与死亡第2卷(1993-1997).北京:中国医药科技出版社,2003:269-295.
  • 4李连弟,饶克勤,孔灵芝,等.中国试点市县恶性肿瘤的发病与死亡第3卷(1999-2002).北京:人民卫生出版社,2007:314-316.
  • 5Parkin DM, Whelan SL, Ferlay J, et al. Cancer incidence in five continents. Vol. VIII. IARC Scientific Publication No. 155. Lyon: IARC, 2002: 745-747.
  • 6Curado MP, Edwards B, Shin HR, et al. Cancer incidence in five continents. Vol. IX. IARC Scientific Publication No. 160. Lyon: IARC, 2008.
  • 7Jensen OM, Parkin DM, MacLennan R, et al. Cancer registration: principles and methods. IARC Scientific Publication No. 95. Lyon.. IARC, 1991.. 101-107.
  • 8Parkin DM, Chen VW, Ferlay J, et al. Comparability and quality control in cancer registration. IARC Technical Report No. 19. Lyon.. IARC, 1994: 35-49.
  • 9Felay J, Burkhard C, Whelan S, et al. Check and conversion programs for cancer registries. IARC Technical Report No. 42. Lyon: IARC, 2005: 11-38.
  • 10Felay J. The IARCcrgTools program, http://www, iacr. com. fr/iarccrgtools, htm. IACR. Lyon. 2006.

共引文献200

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部